e-learning
resources
Barcelona 2013
Monday, 09.09.2013
New frontiers for EBUS-TBNA: the mediastinum and beyond
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The outcome of lymph nodes previously sampled with EBUS-TBNA and deemed "inadequate" - what lessons can be learnt?
M. Evison, P. Crosbie, J. Martin, P. Barber, R. Booton (Manchester, United Kingdom)
Source:
Annual Congress 2013 –New frontiers for EBUS-TBNA: the mediastinum and beyond
Session:
New frontiers for EBUS-TBNA: the mediastinum and beyond
Session type:
Oral Presentation
Number:
2003
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Evison, P. Crosbie, J. Martin, P. Barber, R. Booton (Manchester, United Kingdom). The outcome of lymph nodes previously sampled with EBUS-TBNA and deemed "inadequate" - what lessons can be learnt?. Eur Respir J 2013; 42: Suppl. 57, 2003
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Winston Rajkumar - 18.10.2013 21:25
Well designed. Well presented.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Challenges in the management of SCLC
Related content which might interest you:
Improved negative predictive value of EBUS-TBNA in isolated mediastinal / hilar lymphadenopathy: Why and what it means for patients?
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
The role of number of lymph node passes and methods of pathological examination in the adequacy specimens of EBUS-TBNA in the verification of mediastinal lymphadenopathy
Source: Annual Congress 2013 –VATS, interventional endoscopy and tracheal surgery
Year: 2013
Features predicting malignancy in mediastinal lymph nodes by endobronchial ultrasound in Indian setting: Is it different?
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
EBUS TBNA negative lymph nodes risk stratification model: A tool for multidisciplinary team
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
Is there agreement for optimal transbronchial sampling positions in lymph nodes?
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
PET and endobronchial ultrasound. SUV value of mediastinal lymph nodes suspicious for malignancy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
Efficacy of conventional TBNA in patients with mediastinal adenopathies - A role of cytopathologist
Source: International Congress 2015 – Sedation and educational issues in bronchoscopy: basic bronchoscopic techniques
Year: 2015
No additional diagnostic gain of mediastinoscopy following sytematically and thouroughly performed mediastinal staging by EBUS-TBNA
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Utility of EUS-B-FNA for the diagnosis of EBUS-TBNA inaccessible intrathoracic lesions
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Multigene mutation analysis of mediastinal and hilar lymph nodes sampled by endobronchial unltrasound-guided needle aspiration
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Elastography strain ratio in the staging of mediastinal lymph nodes
Source: International Congress 2014 – EBUS-TBNA: beyond the tracheobronchial wall
Year: 2014
Isolated mediastinal lymphadenopathy - How does EBUS-TBNA perform in clinical practice?
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
EBUS in real life: Primary diagnosis and mediastinal staging
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Ultrasonographic evaluation of mediastinal lymph nodes using endobronchial ultrasound
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013
Applicability of TBNA to peripheral lung lesion when transbronchial biopsy fails
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Endobronchial ultrasound elastography type classification in the diagnosis of mediastinal and hilar lymph nodes
Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology
Year: 2015
Profile of non-neoplasic mediastinal lymph nodes (NNLN) during the study of lung cáncer (LC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept